FDA Approves Unknown Drug — VIWIT PHARM
**VIWIT PHARM** announced U.S. approval for its ANDA application this week, marking a significant step toward market entry. This regulatory clearance is poised to offer widespread generic access and drive revenue growth upon commercialization.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed